813 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
Better Buy: Amgen Inc. vs. Pfizer https://www.fool.com/investing/2017/04/24/better-buy-amgen-inc-vs-pfizer.aspx?source=iedfolrf0000001 Apr 24, 2017 - How do Amgen and Pfizer stocks stack up against each other?
This Stock Turned $1,000 Into $1.53 Million in Less Than 33 Years https://www.fool.com/investing/2017/05/23/this-stock-turned-1000-into-153-million-in-less-th.aspx?source=iedfolrf0000001 May 23, 2017 - It's nearly gained as much as Apple, Amazon, and Microsoft combined since their IPOs.
3 Dividend Stocks That Thrive in Market Crashes https://www.fool.com/investing/2017/07/21/3-dividend-stocks-that-thrive-in-market-crashes.aspx?source=iedfolrf0000001 Jul 21, 2017 - Amgen, Inc, Wal-Mart Stores, and Johnson & Johnson could provide safe havens during the next market crash.
3 Great Income Stocks That Could Double Their Dividends https://www.fool.com/investing/2017/09/17/3-great-income-stocks-that-could-double-their-di-2.aspx?source=iedfolrf0000001 Sep 17, 2017 - Nice yields and fast-growing dividends make these stocks great picks for income-seeking investors.
Novartis' Enbrel Biosimilar Gets FDA Panel Recommendation http://www.zacks.com/stock/news/223501/novartis-enbrel-biosimilar-gets-fda-panel-recommendation?cid=CS-ZC-FT-223501 Jul 14, 2016 - Novartis AG (NVS) announced that the FDA's Arthritis Advisory Committee has recommended an approval of the company's proposed biosimilar of Amgen's (AMGN) blockbuster drug, Enbrel (etanercept).
Amgen (AMGN) May Beat Q2 Earnings: Will the Stock Gain? http://www.zacks.com/stock/news/224697/amgen-amgn-may-beat-q2-earnings-will-the-stock-gain?cid=CS-ZC-FT-224697 Jul 25, 2016 - Our proven model shows that Amgen (AMGN) is likely to beat earnings because it has the right combination of two key ingredients.
3 Stocks Could Double Their Dividends -- But Shouldn't https://www.fool.com/investing/2017/04/25/3-stocks-could-double-their-dividends-but-shouldnt.aspx?source=iedfolrf0000001 Apr 25, 2017 - A big dividend raise isn't always the right move for a business.
Better Buy: Amgen Inc. vs. Johnson & Johnson https://www.fool.com/investing/2017/05/07/better-buy-amgen-inc-vs-johnson-johnson.aspx?source=iedfolrf0000001 May 07, 2017 - How Amgen and Johnson & Johnson stack up against each other on growth prospects, valuation, and dividends.
3 Reasons Gilead Sciences, Inc. Is a Better Dividend Stock Than Amgen, Inc. https://www.fool.com/investing/2017/05/24/3-reasons-gilead-sciences-inc-is-a-better-dividend.aspx?source=iedfolrf0000001 May 24, 2017 - Amgen is a great dividend stock. Here's why Gilead Sciences is even better.
3 Charts That Show Why to Buy Gilead Sciences Stock Now https://www.fool.com/investing/2017/07/02/3-charts-that-show-why-to-buy-gilead-sciences-stoc.aspx?source=iedfolrf0000001 Jul 02, 2017 - Why buy Gilead Sciences stock? These charts tell the story.

Pages: 12345678...82

<<<Page 3>